name: Qualitative measurement of 7 or more drugs


name: Quantitative measurement of 7 or more drugs


name: Quantitative measurement of 7 or more substances


name: Adrenocorticotropic hormone (ACTH) stimulation panel for adrenal insufficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for adrenal insufficiency - Measurement of cortisol


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21- hydroxylase deficiency - Measurement of cortisol


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21-hydroxylase deficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21-hydroxylase deficiency - Measurement of 17 hydroxyprogesterone


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency - Measurement of 17 hydroxypregnenolone


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency - Measurement of cortisol


name: Aldosterone suppression evaluation panel - Measurement of aldosterone


name: Aldosterone suppression evaluation panel - Measurement of renin


name: Calcitonin stimulation panel - Measurement of calcitonin


name: Corticotropic releasing hormone (CRH) stimulation panel - Measurement of adrenocorticotropic hormone (ACTH)


name: Corticotropic releasing hormone (CRH) stimulation panel - Measurement of cortisol


name: Chorionic gonadotropin stimulation panel for testosterone response - Measurement of testosterone response


name: Chorionic gonadotropin stimulation panel; estradiol response This panel must include the following: Estradiol, total (82670 x 2 on 3 pooled blood samples)


name: Renal vein renin stimulation panel - Measurement of renin


name: Peripheral vein renin stimulation panel - Measurement of renin


name: Combined rapid anterior pituitary evaluation panel - Measurement of adrenocorticotropic hormone (ACTH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of cortisol


name: Combined rapid anterior pituitary evaluation panel - Measurement of follicle stimulating hormone (FSH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of human growth hormone (HGH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of luteinizing hormone (LH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of prolactin


name: Combined rapid anterior pituitary evaluation panel - Measurement of thyroid stimulating hormone (TSH)


name: 48 hour dexamethasone suppression panel - Measurement of cortisol


name: 48 hour dexamethasone suppression panel - Measurement of free cortisol in urine


name: 48 hour dexamethasone suppression panel - Volume measurement for timed collection of urine


name: Glucagon tolerance panel for insulinoma - Measurement of glucose


name: Glucagon tolerance panel for insulinoma - Measurement of insulin


name: Glucagon tolerance panel for pheochromocytoma - Measurement of fractionated catecholamines


name: Gonadotropin releasing hormone stimulation panel - Measurement of follicle stimulating hormone (FSH)


name: Gonadotropin releasing hormone stimulation panel - Measurement of luteinizing hormone (LH)


name: Growth hormone stimulation panel - Measurement of human growth hormone (HGH)


name: Growth hormone suppression panel - Measurement of glucose


name: Growth hormone suppression panel - Measurement of human growth hormone (HGH)


name: Insulin-induced C-peptide suppression panel - Measurement of C-peptide


name: Insulin-induced C-peptide suppression panel - Measurement of glucose


name: Insulin-induced C-peptide suppression panel - Measurement of insulin


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency - Measurement of cortisol


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency - Measurement of glucose


name: Insulin tolerance panel for growth hormone deficiency - Measurement of glucose


name: Insulin tolerance panel for growth hormone deficiency - Measurement of human growth hormone (HGH)


name: Metyrapone panel - Measurement of 11 deoxycortisol


name: Metyrapone panel - Measurement of cortisol


name: 1 hour thyrotropin releasing hormone (TRH) stimulation panel


name: 1 hour thyrotropin releasing hormone (TRH) stimulation panel - Measurement of thyroid stimulating hormone


name: 2 hour thyrotropin releasing hormone (TRH) stimulation panel


name: 2 hour thyrotropin releasing hormone (TRH) stimulation panel - Measurement of thyroid stimulating hormone (TSH)


name: Manual urinalysis test with examination using microscope, non-automated


name: Qualitative urinalysis (except immunoassay)


name: Semiquantitative urinalysis (except immunoassay)


name: Bacteriuria screen (except by culture or dipstick)


name: Human Platelet Antigen 1 genotyping (HPA-1), integrin, beta 3 [platelet glycoprotein IIIa] (ITGB3), antigen CD61 [GPIIIa]) gene analysis for detection of HPA-1a/b (L33P) common variant


name: Human Platelet Antigen 2 genotyping (HPA-2), glycoprotein Ib [platelet], alpha polypeptide [GPIba] (GP1BA) gene analysis for detection of HPA-2a/b (T145M) common variant


name: Human Platelet Antigen 3 genotyping (HPA-3), integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex] (ITGA2B), antigen CD41 [GPIIb] (ITGA2B) gene analysis for detection of HPA-3a/b (I843S) common variant


name: Human Platelet Antigen 4 genotyping (HPA-4), integrin, beta 3 [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb] (ITGB3) gene analysis for detection of HPA-4a/b (R143Q) common variant


name: Isocitrate dehydrogenase 2 (NADP+P), mitochondrial (IDH2) gene analysis for detection of R172M variant


name: Breast cancer 1 and 2 (BRCA1, BRCA2) full sequence gene analysis and full analysis for detection of deletion and duplication variants


name: Breast cancer 1 and 2 (BRCA1, BRCA2) full analysis for detection of deletion and duplication variants


name: Breast cancer 1 (BRCA1) full analysis for detection of deletion and duplication variants


name: Breast cancer 2 (BRCA2) full analysis for detection of deletion and duplication variants


name: CCND1/IGH (t(11;14)) (eg, mantle cell lymphoma) translocation analysis, major breakpoint, qualitative and quantitative, if performed


name: Gene analysis (CCND1/IGH (t(11;14))) translocation analysis


name: CCND1/IGH (t(11;14)) qualitative and quantitative gene analysis for detection of translocation of major breakpoint


name: CCND1/IGH (t(11;14)) qualitative gene analysis for detection of translocation of major breakpoint


name: ABL proto-oncogene 1, nonreceptor tyrosine kinase (ABL1) gene analysis for detection of variants in the kinase domain


name: Ataxin 7 (ATXN7) gene analysis for detection of abnormal alleles


name: Ataxin 8 opposite strand [nonprotein coding] (ATXN8OS) gene analysis for detection of abnormal alleles


name: NTRK1 (neurotrophic receptor tyrosine kinase 1) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis


name: Neurotrophic receptor tyrosine kinase 1 (NTRK1) gene analysis for detection of translocation


name: NTRK2 (neurotrophic receptor tyrosine kinase 2) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis


name: Neurotrophic receptor tyrosine kinase 2 (NTRK2) gene analysis for detection of translocation


name: NTRK3 (neurotrophic receptor tyrosine kinase 3) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 3) translocation analysis


name: Neurotrophic receptor tyrosine kinase 3 (NTRK3) gene analysis for detection of translocation


name: NTRK (neurotrophic receptor tyrosine kinase 1, 2, and 3) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 1, 2, and 3) translocation analysis


name: Neurotrophic receptor tyrosine kinase 1,2, and 3 (NTRK1, 2, and 3) gene analysis for detection of translocation


name: B-Raf proto-oncogene, serine/threonine kinase (BRAF) gene analysis for detection of V600E variant


name: Cystic fibrosis transmembrane conductance regulator (CFTR) gene analysis for detection of deletion and duplication variants


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *2 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *3 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *4 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *5 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *6 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *7 variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481F variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481R variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481S variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of G719A variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of G719S variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of L858R variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of L861Q variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of T790M variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of common variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of exon 19 LREA deletion variant


name: Fanconi anemia, complementation group C (FANCC) gene analysis for detection of IVS4+4A>T variant


name: Fanconi anemia, complementation group C (FANCC) gene analysis for detection of common variant


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exon 14


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exon 15


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exons 14 and 15


name: Gap junction protein, beta 2, 26kDa, connexin 26 (GJB2) full gene sequence analysis


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1278insTATC variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1278insTATC, 1421+1G>C, and G269S variants


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1421+1G>C variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of G269S variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of common variant


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative buccal swab for posttransplant recipient germline and donor testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative germline tissue specimen for posttransplant recipient germline and donor testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative specimen for pretransplant recipient and donor germline testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and donor specimen


name: Comparative analysis using Short Tandem Repeat (STR) markers of patient and specimen, each additional specimen


name: Comparative analysis using short tandem repeat (STR) marker, each additional specimen


name: Chimerism analysis post transplantation, with cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and CD3-positive T cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and CD33-positive myeloid cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and cell selection


name: Huntingtin (HTT) gene analysis for detection of abnormal alleles


name: Huntington disease gene analysis for detection of abnormal alleles


name: Huntingtin (HTT) gene analysis for characterization of alleles


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in codon 12


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in codon 13


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in exon 2


name: Kirsten rat sarcoma viral oncogene homolog (KRAS) gene analysis for additional variants


name: IGH@/BCL2 (t(14;18)) (eg, follicular lymphoma) translocation analysis, major breakpoint region (MBR) and minor cluster region (mcr) breakpoints, qualitative or quantitative


name: Gene analysis (IGH@/BCL2 (t(14;18)) translocation analysis


name: IGH@/BCL2 (t(14;18)) qualitative gene analysis for detection of translocation of major breakpoint region and minor cluster breakpoints


name: IGH@/BCL2 (t(14;18)) quantitative gene analysis for detection


name: JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13)


name: Gene analysis (Janus kinase 2) targeted sequence analysis


name: Janus kinase 2 (JAK2) targeted sequence gene analysis


name: Janus kinase 2 (JAK2) targeted sequence gene analysis of exons 12, 13


name: Test for detecting genes associated with colon cancer, promoter methylation analysis


name: MutL homolog 1, colon cancer, nonpolyposis type 2 (MLH1) gene analysis for detection of promoter methylation variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *2 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *3 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *4 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *5 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *6 variant


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 20


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 7


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 9


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exons 7, 9, and 20


name: Measurement of prostate cancer antigen 3 [nonprotein coding] and kallikrein-related peptidase 3 [prostate specific antigen] (PCA3/KLK3) ratio


name: Platelet-derived growth factor receptor, alpha polypeptide (PDGFRA) targeted gene sequence analysis


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, common breakpoints


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, intron 3 and intron 6 breakpoints


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, common breakpoints


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, intron 3 and intron 6 breakpoints


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single exon 6 breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 3 breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 6 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single exon 6 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 3 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 6 breakpoint


name: Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) gene analysis for detection of known familial variant


name: Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) gene analysis for detection of deletion and duplication variants


name: Phosphatase and tensin homolog (PTEN) gene analysis for detection of deletion and duplication variants


name: Peripheral myelin protein 22 (PMP22) gene analysis for detection of deletion and duplication variants


name: Small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A (SNRPN/UBE3A) analysis for detection of methylated variant


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; common variants (eg, W515A, W515K, W515L, W515R)


name: Gene analysis (MPL proto-oncogene, thrombopoietin receptor) for detection of common variants


name: MPL proto-oncogene, thrombopoietin receptor (MLP) gene analysis for detection of common variants


name: MPL proto-oncogene, thrombopoietin receptor (MLP) gene analysis for detection of common variants W515A, W515K, W515L, W515R


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; sequence analysis, exon 10


name: Gene analysis (MPL proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10


name: MPL proto-oncogene, thrombopoietin receptor (MLP) sequence gene analysis of exon 10


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using amplification method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using polymerase chain reaction method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using Southern blot method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using direct probe method


name: Telomerase reverse transcriptase (TERT) targeted gene sequence analysis of promoter region


name: SF3B1 (splicing factor [3b] subunit B1) (eg, myelodysplastic syndrome/acute myeloid leukemia) gene analysis, common variants (eg, A672T, E622D, L833F, R625C, R625L)


name: Gene analysis (splicing factor [3b] subunit B1) for detection of common variants


name: Splicing factor [3b] subunit B1) (SF3B1) gene analysis for detection of common variants


name: Splicing factor [3b] subunit B1) (SF3B1) gene analysis for detection of common variants A672T, E622D, L833F, R625C, R625L


name: SRSF2 (serine and arginine-rich splicing factor 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, P95H, P95L)


name: Gene analysis (serine and arginine-rich splicing factor 2) for detection of common variants


name: Serine and arginine-rich splicing factor 2 (SRSF2) gene analysis for detection of common variants


name: Serine and arginine-rich splicing factor 2 (SRSF2) gene analysis for detection of common variants P95H, P95L


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; full gene sequence


name: Gene analysis (tumor protein 53) full sequence analysis


name: Tumor protein 53 (TP53) full sequence gene analysis


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; targeted sequence analysis (eg, 4 oncology)


name: Gene analysis (tumor protein 53) targeted sequence analysis


name: Tumor protein 53 (TP53) targeted sequence gene analysis


name: Tumor protein 53 (TP53) targeted sequence gene analysis of 4 oncology


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; known familial variant


name: Gene analysis (tumor protein 53) targeted sequence analysis for detection of known familial variant


name: Tumor protein 53 (TP53) gene analysis for detection of known familial variant


name: Vitamin K epoxide reductase complex, subunit 1 (VKORC1) gene analysis for detection of -1639G>A variant


name: Vitamin K epoxide reductase complex, subunit 1 (VKORC1) gene analysis for detection of -c173+1000C>T variant


name: U2AF1 (U2 small nuclear RNA auxiliary factor 1) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, S34F, S34Y, Q157R, Q157P)


name: Gene analysis (U2 small nuclear RNA auxiliary factor 1) for detection of common variants


name: U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene analysis for detection of common variants


name: U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene analysis for detection of common variants S34F, S34Y, Q157R, Q157


name: ZRSR2 (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variant(s) (eg, E65fs, E122fs, R448fs)


name: Gene analysis (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) for detection of common variants


name: Zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2 (ZRSR2) gene analysis for detection of common variants


name: Zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2 (ZRSR2) gene analysis for detection of common variants E65fs, E122fs, R448fs


name: Hemoglobin, subunit beta (HBB) gene analysis for detection of HbC, HbE, and HbS variants


name: Complete low resolution human leukocyte antigen (HLA) Class I typing of HLA-A, HLA-B, and HLA-C


name: Low resolution human leukocyte antigen (HLA) Class I typing of single locus


name: Low resolution human leukocyte antigen (HLA) Class I typing of each antigen equivalent


name: Low resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB1


name: Low resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB3/4/5


name: Low resolution human leukocyte antigen (HLA) Class II typing of each locus


name: Low resolution human leukocyte antigen (HLA) Class II typing of each antigen equivalent


name: High resolution human leukocyte antigen (HLA) Class I and II typing of HLA-A, HLA-B, HLA-C,and HLA-DRB1


name: Complete high resolution human leukocyte antigen (HLA) Class I typing of HLA-A, HLA-B, and HLA-C


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 locus


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 allele


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 allele group


name: High resolution human leukocyte antigen (HLA) Class II typing of 1 locus


name: High resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB3/4/5


name: High resolution human leukocyte antigen (HLA) Class II typing of 1 allele group


name: High resolution human lymphocyte antigen Class II typing of 1 allele


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 2 - ABL prot-oncogene 1, non-receptor tyrosine kinase (ABL 1) gene analysis for detection of T313I variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of F1388del variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of c.3898-9G>A (c.3992-9G>A) and F1388del variants


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of c.3898-9G>A (c.3992-9G>A) variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E and Y42H variants


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of Y42H variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of G16R and Q27E variants


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of G16R variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of Q27E variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of R3500Q and R3500W variants


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of R3500Q variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of R3500W variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein E (APOE) gene analysis for detection of *2 variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein E (APOE) gene analysis for detection of *2,*3, and *4 variants


name: Molecular pathology procedure, Level 2 - Apolipoprotein E (APOE) gene analysis for detection of *3 variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein E (APOE) gene analysis for detection of *4 variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein E (APOE) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Coagulation factor XI (F11) gene analysis for detection of E117X (Type II) variant


name: Molecular pathology procedure, Level 2 - Coagulation factor XI (F11) gene analysis for detection of E117X (Type II), F283L (Type III), IVS14del14, and IVS14+1G>A (Type I) variants


name: Molecular pathology procedure, Level 2 - Coagulation factor XI (F11) gene analysis for detection of IVS14+1G>A (Type I) variant


name: Molecular pathology procedure, Level 2 - Coagulation factor XI (F11) gene analysis for detection of IVS14del14 variant


name: Molecular pathology procedure, Level 2 - Complement factor H/age-related maculopathy susceptibility 2 (CFH/ARMS2) gene analysis for detection of A69S (ARMS2) variant


name: Molecular pathology procedure, Level 2 - Complement factor H/age-related maculopathy susceptibility 2 (CFH/ARMS2) gene analysis for detection of Y402H (CFH) and A69S (ARMS2) variants


name: Molecular pathology procedure, Level 2 - Complement factor H/age-related maculopathy susceptibility 2 (CFH/ARMS2) gene analysis for detection of Y402H (CFH) variant


name: Molecular pathology procedure, Level 2 - Complement factor H/age-related maculopathy susceptibility 2 (CFH/ARMS2) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Cystathionine-beta-synthase (CBS) gene analysis for detection of G307S variant


name: Molecular pathology procedure, Level 2 - Cystathionine-beta-synthase (CBS) gene analysis for detection of I278T and G307S variants


name: Molecular pathology procedure, Level 2 - Cystathionine-beta-synthase (CBS) gene analysis for detection of I278T variant


name: Molecular pathology procedure, Level 2 - Cystathionine-beta-synthase (CBS) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - DEK/NUP214 (t(6;9)) translocation analysis


name: Molecular pathology procedure, Level 2 - EML4/ALK (inv(2)) inversion analysis


name: Molecular pathology procedure, Level 2 - EML4/ALK (inv(2)) translocation analysis


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of 1138G>A variant


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of 1138G>A, 1138G>C, 1620C>A, and 1620C>G variants


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of 1138G>C variant


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of 1620C>A variant


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of 1620C>G variant


name: Molecular pathology procedure, Level 2 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of 2282del4 variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of 3702delG variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of R2447X variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of R501X variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of R501X, 2282del4, R2447X, S3247X, and 3702delG variants


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of S3247X variant


name: Molecular pathology procedure, Level 2 - Filaggrin (FLG) gene analysis for detection of common variants


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of IVS2-2A>G variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of K285N variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of L195P variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of L218L/N314D variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of N314D variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of P171S variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of Q188R variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of Q188R, S135L, K285N, T138M, L195P, Y209C, IVS2-2A>G, P171S, del5kb, N314D, and L218L/N314D variants


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of S135L variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of T138M variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of Y209C variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Galactose-1-phosphate uridylyltransferase (GALT) gene analysis for detection of del5kb variant


name: Molecular pathology procedure, Level 2 - Galactosylceramidase (GALC) gene analysis for detection of 30-kb deletion variant


name: Molecular pathology procedure, Level 2 - Galactosylceramidase (GALC) gene analysis for detection of c.857G>A and 30-kb deletion variants


name: Molecular pathology procedure, Level 2 - Galactosylceramidase (GALC) gene analysis for detection of c.857G>A variant


name: Molecular pathology procedure, Level 2 - Gene analysis for detection of methylated variant


name: Molecular pathology procedure, Level 2 - Gene analysis for detection of somatic variant


name: Molecular pathology procedure, Level 2 - Imprinted maternally expressed transcript [nonprotein coding] (H19) gene analysis for detection of methylated variant


name: Molecular pathology procedure, Level 2 - KCNQ1 overlapping transcript 1 (nonprotein coding) (KCNQ1OT1) gene analysis for detection of methylated variant


name: Molecular pathology procedure, Level 2 - Leucine-rich repeat kinase 2 (LRRK2) gene analysis for G2019S variant


name: Molecular pathology procedure, Level 2 - Leucine-rich repeat kinase 2 (LRRK2) gene analysis for I2020T variant


name: Molecular pathology procedure, Level 2 - Leucine-rich repeat kinase 2 (LRRK2) gene analysis for R1441G variant


name: Molecular pathology procedure, Level 2 - Leucine-rich repeat kinase 2 (LRRK2) gene analysis for R1441G, G2019S, and I2020T variants


name: Molecular pathology procedure, Level 2 - Leucine-rich repeat kinase 2 (LRRK2) gene analysis for common variant


name: Molecular pathology procedure, Level 2 - Maternally expressed 3 [nonprotein coding]/delta-like 1 homolog [Drosophila] (MEG3/DLK1) gene analysis for detection of methylated variant


name: Molecular pathology procedure, Level 2 - Mediator complex subunit 12 (MED12) gene analysis for N1007S variant


name: Molecular pathology procedure, Level 2 - Mediator complex subunit 12 (MED12) gene analysis for R961W and N1007S variants


name: Molecular pathology procedure, Level 2 - Mediator complex subunit 12 (MED12) gene analysis for R961W variant


name: Molecular pathology procedure, Level 2 - Mediator complex subunit 12 (MED12) gene analysis for common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded 12S RNA (MT-RNR1) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded 12S RNA (MT-RNR1) gene analysis for detection of m.1494C>T variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded 12S RNA (MT-RNR1) gene analysis for detection of m.1555A>G and m.1494C>T variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded 12S RNA (MT-RNR1) gene analysis for detection of m.1555A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded ATP synthase 6 (MT-ATP6) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded ATP synthase 6 (MT-ATP6) gene analysis for detection of m.8993T>C variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded ATP synthase 6 (MT-ATP6) gene analysis for detection of m.8993T>G and m.8993T>C variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded ATP synthase 6 (MT-ATP6) gene analysis for detection of m.8993T>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded NADH dehydrogenase 4, mitochondrially encoded NADH dehydrogenase 6 (MT-ND4, MT-ND6) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded NADH dehydrogenase 4, mitochondrially encoded NADH dehydrogenase 6 (MT-ND4, MT-ND6) gene analysis for detection of m.11778G>A variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded NADH dehydrogenase 4, mitochondrially encoded NADH dehydrogenase 6 (MT-ND4, MT-ND6) gene analysis for detection of m.11778G>A, m.3460G>A, and m.14484T>C variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded NADH dehydrogenase 4, mitochondrially encoded NADH dehydrogenase 6 (MT-ND4, MT-ND6) gene analysis for detection of m.14484T>C variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded NADH dehydrogenase 4, mitochondrially encoded NADH dehydrogenase 6 (MT-ND4, MT-ND6) gene analysis for detection of m.3460G>A variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G] (MT-TL1) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G] (MT-TL1) gene analysis for detection of m.3243A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G], mitochondrially encoded NADH dehydrogenase 5 (MT-TL1 MT-ND5) gene analysis for detection of m.13513G>A variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G], mitochondrially encoded NADH dehydrogenase 5 (MT-TL1 MT-ND5) gene analysis for detection of m.3243A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G], mitochondrially encoded NADH dehydrogenase 5 (MT-TL1 MT-ND5) gene analysis for detection of m.3243A>G, m.3271T>C, m.3252A>G, and m.13513G>A variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G], mitochondrially encoded NADH dehydrogenase 5 (MT-TL1 MT-ND5) gene analysis for detection of m.3252A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA leucine 1 [UUA/G], mitochondrially encoded NADH dehydrogenase 5 (MT-TL1 MT-ND5) gene analysis for detection of m.3271T>C variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA lysine (MT-TK) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA lysine (MT-TK) gene analysis for detection of m.8344A>G and m.8356T>C variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA lysine (MT-TK) gene analysis for detection of m.8344A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA lysine (MT-TK) gene analysis for detection of m.8356T>C variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA serine 1 [UCN], mitochondrially encoded 12S RNA (MT-TS1, MT-RNR1) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA serine 1 [UCN], mitochondrially encoded 12S RNA (MT-TS1, MT-RNR1) gene analysis for detection of m.1555A>G variant


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA serine 1 [UCN], mitochondrially encoded 12S RNA (MT-TS1, MT-RNR1) gene analysis for detection of m.7445A>G and m.1555A>G variants


name: Molecular pathology procedure, Level 2 - Mitochondrially encoded tRNA serine 1 [UCN], mitochondrially encoded 12S RNA (MT-TS1, MT-RNR1) gene analysis for detection of m.7445A>G variant


name: Molecular pathology procedure, Level 2 - MutY homolog (E. coli) (MUTYH) gene analysis for detection of G382D variant


name: Molecular pathology procedure, Level 2 - MutY homolog (E. coli) (MUTYH) gene analysis for detection of Y165C and G382D variants


name: Molecular pathology procedure, Level 2 - MutY homolog (E. coli) (MUTYH) gene analysis for detection of Y165C variant


name: Molecular pathology procedure, Level 2 - MutY homolog (E. coli) (MUTYH) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - NPM1/ALK (t(2;5)) translocation analysis


name: Molecular pathology procedure, Level 2 - Nucleotide-binding oligomerization domain containing 2 (NOD2) gene analysis for SNP 12 variant


name: Molecular pathology procedure, Level 2 - Nucleotide-binding oligomerization domain containing 2 (NOD2) gene analysis for SNP 13 variant


name: Molecular pathology procedure, Level 2 - Nucleotide-binding oligomerization domain containing 2 (NOD2) gene analysis for SNP 8 variant


name: Molecular pathology procedure, Level 2 - Nucleotide-binding oligomerization domain containing 2 (NOD2) gene analysis for SNP 8, SNP 12, and SNP 13 variants


name: Molecular pathology procedure, Level 2 - Nucleotide-binding oligomerization domain containing 2 (NOD2) gene analysis for common variant


name: Molecular pathology procedure, Level 2 - PAX8/PPARG (t(2;3) (q13;p25)) translocation analysis


name: Molecular pathology procedure, Level 2 - Phosphorylase, glycogen, muscle (PYGM) gene analysis for detection of G205S variant


name: Molecular pathology procedure, Level 2 - Phosphorylase, glycogen, muscle (PYGM) gene analysis for detection of R50X and G205S variants


name: Molecular pathology procedure, Level 2 - Phosphorylase, glycogen, muscle (PYGM) gene analysis for detection of R50X variant


name: Molecular pathology procedure, Level 2 - Phosphorylase, glycogen, muscle (PYGM) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Preferentially expressed antigen in melanoma (PRAME) expression analysis


name: Molecular pathology procedure, Level 2 - Protease, serine, 1 [trypsin 1] (PRSS1) gene analysis for detection of A16V variant


name: Molecular pathology procedure, Level 2 - Protease, serine, 1 [trypsin 1] (PRSS1) gene analysis for detection of N29I variant


name: Molecular pathology procedure, Level 2 - Protease, serine, 1 [trypsin 1] (PRSS1) gene analysis for detection of N29I, A16Vm, and R122H variants


name: Molecular pathology procedure, Level 2 - Protease, serine, 1 [trypsin 1] (PRSS1) gene analysis for detection of R122H variant


name: Molecular pathology procedure, Level 2 - Protease, serine, 1 [trypsin 1] (PRSS1) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Qualitative DEK/NUP214 (t(6;9)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative ETV6/RUNX1 (t(12;21)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative EWSR1/ATF1 (t(12;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative EWSR1/ERG (t(21;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative EWSR1/FLI1 (t(11;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative EWSR1/WT1 (t(11;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative FIP1L1/PDGFRA (del[4q12]) gene analysis


name: Molecular pathology procedure, Level 2 - Qualitative FOXO1/PAX3 (t(2;13)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative FUS/DDIT3 (t(12;16)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative IGH@/BCL2 (t(14;18)) translocation analysis for detection of single major breakpoint region breakpoint


name: Molecular pathology procedure, Level 2 - Qualitative IGH@/BCL2 (t(14;18)) translocation analysis for detection of single minor cluster region breakpoint


name: Molecular pathology procedure, Level 2 - Qualitative MLL/AFF1 (t(4;11)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative MLL/MLLT3 (t(9;11)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative RUNX1/RUNX1T1 (t(8;21)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative SS18/SSX1 (t(X;18)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative SS18/SSX2 (t(X;18)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative DEK/NUP214 (t(6;9)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative ETV6/RUNX1 (t(12;21)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative EWSR1/ATF1 (t(12;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative EWSR1/ERG (t(21;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative EWSR1/FLI1 (t(11;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative EWSR1/WT1 (t(11;22)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative FIP1L1/PDGFRA (del[4q12]) gene analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative FOXO1/PAX3 (t(2;13)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative FOXO1/PAX7 (t(2;13)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative FUS/DDIT3 (t(12;16)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative IGH@/BCL2 (t(14;18)) translocation analysis for detection of single major breakpoint region breakpoint


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative IGH@/BCL2 (t(14;18)) translocation analysis for detection of single minor region cluster


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative MLL/AFF1 (t(4;11)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative MLL/MLLT3 (t(9;11)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative RUNX1/RUNX1T1 (t(8;21)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative SS18/SSX1 (t(X;18)) translocation analysis


name: Molecular pathology procedure, Level 2 - Qualitative and quantitative SS18/SSX2 (t(X;18)) translocation analysis


name: Molecular pathology procedure, Level 2 - Von Willebrand factor (VWF) gene analysis for detection of R816W variant


name: Molecular pathology procedure, Level 2 - Von Willebrand factor (VWF) gene analysis for detection of R854Q variant


name: Molecular pathology procedure, Level 2 - Von Willebrand factor (VWF) gene analysis for detection of T791M variant


name: Molecular pathology procedure, Level 2 - Von Willebrand factor (VWF) gene analysis for detection of T791M, R816W, and R854Q variants


name: Molecular pathology procedure, Level 2 - Von Willebrand factor (VWF) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite marker D18S55


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite marker D18S58


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite marker D18S6


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite marker D18S61


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite marker D18S69


name: Molecular pathology procedure, Level 3 - Chromosome 18q allelic imbalance assessment of microsatellite markers D18S55, D18S58, D18S61, D18S64, and D18S69


name: Molecular pathology procedure, Level 3 - Chromosome 1p-/19q- deletion analysis


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of 30-kb deletion variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of G110VfsX21 variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of I172N variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of IVS2-13G variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of IVS2-13G, P30L, I172N, exon 6 mutation cluster (I235N, V236E, M238K), V281L, L307FfsX6, Q318X, R356W, P453S, G110VfsX21, and 30-kb deletion variants


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of L307FfsX6 variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of P30L variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of P453S variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of Q318X variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of R356W variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of V281L variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 3 - Cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2) gene analysis for detection of exon 6 mutation cluster (I235N, V236E, M238K)


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of 2-10 somatic variants


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of T-cell receptor gene rearrangement


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of deletion variant of 1 exon


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of duplication and deletion variants of 1 exon


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of duplication variant of 1 exon


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of immunoglobulin receptor gene rearrangement


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of loss of heterozygosity (LOH)


name: Molecular pathology procedure, Level 3 - Gene analysis for detection of uniparental disomy (UDP)


name: Molecular pathology procedure, Level 3 - IGH@/BCL2 (t(14;18)) translocation analysis for major breakpoint region (MBR) and minor cluster region (MCR) breakpoints


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of A744S variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of E148Q variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of E148Q, P369S, F479L, M680I, I692del, M694V, M694I, K695R, V726A, A744S, and R761H variants


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of F479L variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of I692del variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of K695R variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of M680I variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of M694I variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of M694V variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of P369S variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of R761H variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of V726A variant


name: Molecular pathology procedure, Level 3 - Mediterranean fever (MEFV) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 3 - Qualitative COL1A1/PDGFB (t(17;22)) translocation analysis for multiple breakpoints


name: Molecular pathology procedure, Level 3 - Qualitative and quantitative COL1A1/PDGFB (t(17;22)) translocation analysis for multiple breakpoints


name: Molecular pathology procedure, Level 3 - Receptor 1/progesterone receptor (ESR1/PGR) ratio


name: Molecular pathology procedure, Level 3 - T cell antigen receptor, delta (TCD@) gene rearrangement analysis for detection of abnormal clonal population


name: Molecular pathology procedure, Level 3 - Uniparental disomy (UPD) short tandem repeat (STR) analysis


name: Level 4 molecular pathology procedure - Aristaless-related homeobox (ARX), deletion analysis


name: Level 4 molecular pathology procedure - Aristaless-related homeobox (ARX) deletion and duplication analysis


name: Level 4 molecular pathology procedure - Aristaless-related homeobox (ARX) duplication analysis


name: Level 4 molecular pathology procedure - Carboxyl ester lipase (bile salt-stimulated lipase) (CEL), targeted sequence analysis of exon 11


name: Level 4 molecular pathology procedure - Carboxyl ester lipase (bile salt-stimulated lipase) (CEL), targeted sequence analysis of exon 11 for detection of c.1686delT variant


name: Level 4 molecular pathology procedure - Carboxyl ester lipase (bile salt-stimulated lipase) (CEL) targeted sequence analysis of exon 11 for detection of c.1785delC and c.1686delT variants


name: Level 4 molecular pathology procedure - Carboxyl ester lipase (bile salt-stimulated lipase) (CEL) targeted sequence analysis of exon 11 for detection of c.1785delC variant


name: Level 4 molecular pathology procedure - Catenin (cadherin-associated protein) beta 1, 88kDa (CTNNB1) targeted sequence analysis


name: Level 4 molecular pathology procedure - Catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1) targeted sequence analysis of exon 3


name: Level 4 molecular pathology procedure - Coagulation factor VIII (F8), inversion analysis of intron 1 and intron 22A


name: Level 4 molecular pathology procedure - Coagulation factor XII (F12) targeted sequence analysis of exon 9


name: Level 4 molecular pathology procedure - DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A) targeted sequence analysis


name: Level 4 molecular pathology procedure - DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A) targeted sequence analysis of exon 23


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of AZFa deletion


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of AZFa, AZFb, AZFc, and AZFd deletions


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of AZFb deletion


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of AZFc deletion


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of AZFd deletion


name: Level 4 molecular pathology procedure - Deleted in azoospermia and sex determining region Y (DAZ/SRY) gene analysis for detection of common deletions


name: Level 4 molecular pathology procedure - Epithelial cell adhesion molecule (EPCAM) deletion analysis


name: Level 4 molecular pathology procedure - Epithelial cell adhesion molecule (EPCAM) deletion and duplication analysis


name: Level 4 molecular pathology procedure - Epithelial cell adhesion molecule (EPCAM) duplication analysis


name: Level 4 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis


name: Level 4 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exon 7


name: Level 4 molecular pathology procedure - Gap junction protein, beta 1 (GJB1) full gene sequence analysis


name: Level 4 molecular pathology procedure - Guanine nucleotide-binding protein G(q) subunit alpha (GNAQ) for detection of Q209 variant


name: Level 4 molecular pathology procedure - Guanine nucleotide-binding protein G(q) subunit alpha (GNAQ) for detection of R183 and Q209 variants


name: Level 4 molecular pathology procedure - Guanine nucleotide-binding protein G(q) subunit alpha (GNAQ) for detection of R183 variant


name: Level 4 molecular pathology procedure - Guanine nucleotide-binding protein G(q) subunit alpha (GNAQ) for detection of common variants


name: Level 4 molecular pathology procedure - Human erythrocyte antigen gene analysis for detection of common variants


name: Level 4 molecular pathology procedure - Killer cell immunoglobulin-like receptor (KIR) genotyping of KIR family genes


name: Level 4 molecular pathology procedure - MHC class I polypeptide-related sequence A (MICA) for detection of *001 and *002 variants


name: Level 4 molecular pathology procedure - MHC class I polypeptide-related sequence A (MICA) for detection of *001 variant


name: Level 4 molecular pathology procedure - MHC class I polypeptide-related sequence A (MICA) for detection of *002 variant


name: Level 4 molecular pathology procedure - MHC class I polypeptide-related sequence A (MICA) for detection of common variants


name: Level 4 molecular pathology procedure - Melanocortin 4 receptor (MC4R) full gene sequence analysis


name: Level 4 molecular pathology procedure - Mitochondrially encoded 12S RNA (MT-RNR1) full gene sequence analysis


name: Level 4 molecular pathology procedure - Mitochondrially encoded tRNA serine 1 (MT-TS1) full gene sequence analysis


name: Level 4 molecular pathology procedure - NHL repeat containing 1 (NHLRC1) full gene sequence analysis


name: Level 4 molecular pathology procedure - Norrie disease [pseudoglioma] (NDP) deletion analysis


name: Level 4 molecular pathology procedure - Norrie disease [pseudoglioma] (NDP) deletion and duplication analysis


name: Level 4 molecular pathology procedure - Norrie disease [pseudoglioma] (NDP) duplication analysis


name: Level 4 molecular pathology procedure - Paired-like homeobox 2b (PHOX2B) deletion analysis


name: Level 4 molecular pathology procedure - Paired-like homeobox 2b (PHOX2B) duplication and deletion analysis


name: Level 4 molecular pathology procedure - Paired-like homeobox 2b (PHOX2B) duplication analysis


name: Level 4 molecular pathology procedure - Phospholamban (PLN) full gene sequence analysis


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis of exon 4


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis of exon 5


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis of exon 7


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis of exons 4, 5, 7, and pseudogene


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis of pseudogene


name: Level 4 molecular pathology procedure - Rh blood group, D antigen (RHD) deletion analysis performed on cell-free fetal DNA in maternal blood


name: Level 4 molecular pathology procedure- SH2 domain containing 1A (SH2D1A) deletion analysis


name: Level 4 molecular pathology procedure - SH2 domain containing 1A (SH2D1A) deletion and duplication analysis


name: Level 4 molecular pathology procedure - SH2 domain containing 1A (SH2D1A) duplication analysis


name: Level 4 molecular pathology procedure - Twist homolog 1 [Drosophila] (TWIST1) deletion analysis


name: Level 4 molecular pathology procedure - Twist homolog 1 [Drosophila] (TWIST1) deletion and duplication analysis


name: Level 4 molecular pathology procedure - Twist homolog 1 [Drosophila] (TWIST1) duplication analysis


name: Level 4 molecular pathology procedure - Ubiquitin-like modifier activating enzyme 1 (UBA1) targeted sequence analysis


name: Level 4 molecular pathology procedure - Ubiquitin-like modifier activating enzyme 1 (UBA1) targeted sequence analysis of exon 15


name: Level 4 molecular pathology procedure - Von Hippel-Lindau tumor suppressor (VHL) deletion analysis


name: Level 4 molecular pathology procedure - Von Hippel-Lindau tumor suppressor (VHL) deletion and duplication analysis


name: Level 4 molecular pathology procedure - Von Hippel-Lindau tumor suppressor (VHL) duplication analysis


name: Level 4 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis


name: Level 4 molecular pathology procedure - von Willebrand factor (VWF) targeted sequence analysis of exon 28


name: Level 5 molecular pathology procedure - Acyl-CoA dehydrogenase, C-2 to C-3 short chain (ACADS) targeted sequence analysis


name: Level 5 molecular pathology procedure - Acyl-CoA dehydrogenase, C-2 to C-3 short chain (ACADS) targeted sequence analysis of exons 5 and 6


name: Level 5 molecular pathology procedure - Aquaporin 2 [collecting duct] (AQP2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Arginine vasopressin receptor 2 (AVPR2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Aristaless related homeobox (ARX) full gene sequence analysis


name: Level 5 molecular pathology procedure -Bardet-Biedl syndrome 10 (BBS10) full gene sequence analysis


name: Level 5 molecular pathology procedure - Biotinidase (BTD) full gene sequence analysis


name: Level 5 molecular pathology procedure - CD40 ligand (CD40LG) full gene sequence analysis


name: Level 5 molecular pathology procedure - Carnitine palmitoyltransferase 2 (CPT2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Caveolin 3 (CAV3) full gene sequence analysis


name: Level 5 molecular pathology procedure - Chromosome 10 open reading frame 2 (C10orf2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Clarin 1 (CLRN1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Cone-rod homeobox (CRX) full gene sequence analysis


name: Level 5 molecular pathology procedure - Cyclin-dependent kinase inhibitor 2A (CDKN2A) full gene sequence analysis


name: Level 5 molecular pathology procedure - Cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Cytochrome c oxidase subunit VIb polypeptide 1 (COX6B1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Early growth response 2 (EGR2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Emerin (EMD) deletion analysis


name: Level 5 molecular pathology procedure - Emerin (EMD) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Emerin (EMD) duplication analysis


name: Level 5 molecular pathology procedure - Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A) full gene sequence analysis


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for characterization of chromosome 4A and 4B haplotypes


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for characterization of chromosome 4A haplotype


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for characterization of chromosome 4B haplotype


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for characterization of haplotype


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for detection of abnormal alleles


name: Level 5 molecular pathology procedure - Facioscapulohumeral muscular dystrophy 1A (FSHMD1A) gene analysis for detection of deleted alleles


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 2 (FGFR2) targeted sequence analysis


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 2 (FGFR2) targeted sequence analysis of exon 10


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 2 (FGFR2) targeted sequence analysis of exon 8


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 2 (FGFR2) targeted sequence analysis of exons 8 and 10


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exon 12


name: Level 5 molecular pathology procedure -Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exon 13


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exon 8


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exon 11


name: Level 5 molecular pathology procedure - Fibroblast growth factor receptor 3 (FGFR3) targeted sequence analysis of exons 8, 11, 12, and 13


name: Level 5 molecular pathology procedure - Forkhead box G1 (FOXG1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Four and a half LIM domains 1 (FHL1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Fukutin related protein (FKRP) full gene sequence analysis


name: Level 5 molecular pathology procedure - Glycoprotein Ib [platelet], beta polypeptide (GP1BB) full gene sequence analysis


name: Level 5 molecular pathology procedure - HNF1 homeobox B (HBB) deletion analysis


name: Level 5 molecular pathology procedure - HNF1 homeobox B (HBB) deletion and duplication analysis


name: Level 5 molecular pathology procedure - HNF1 homeobox B (HBB) duplication analysis


name: Level 5 molecular pathology procedure - Heat shock 27kDa protein 1 (HSPB1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (HSD3B2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Hydroxysteroid [11-beta] dehydrogenase 2 (HSD11B2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Insulin (INS) full gene sequence analysis


name: Level 5 molecular pathology procedure - Lipopolysaccharide-induced TNF factor (LITAF) full gene sequence analysis


name: Level 5 molecular pathology procedure - Mediterranean fever (MEFV) full gene sequence analysis


name: Level 5 molecular pathology procedure - Methylmalonic aciduria [cobalamin deficiency] cblC type, with homocystinuria (MMACHC) full gene sequence analysis


name: Level 5 molecular pathology procedure - Multiple endocrine neoplasia I (MEN1) deletion analysis


name: Level 5 molecular pathology procedure - Multiple endocrine neoplasia I (MEN1) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Multiple endocrine neoplasia I (MEN1) duplication analysis


name: Level 5 molecular pathology procedure - NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 1, 7.5kDa (NDUFA1) full gene sequence analysis


name: Level 5 molecular pathology procedure - NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, assembly factor 2 (NDUFAF2) full gene sequence analysis


name: Level 5 molecular pathology procedure - NADH dehydrogenase [ubiquinone] Fe-S protein 4, 18kDa [NADH-coenzyme Q reductase] (NDUFS4) full gene sequence analysis


name: Level 5 molecular pathology procedure - Neuroligin 4, X-linked (NLGN4X) deletion analysis


name: Level 5 molecular pathology procedure - Neuroligin 4, X-linked (NLGN4X) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Neuroligin 4, X-linked (NLGN4X) duplication analysis


name: Level 5 molecular pathology procedure - Niemann-Pick disease, type C2 (epididymal secretory protein E1) (NPC2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Non-imprinted in Prader-Willi/Angelman syndrome 1 (NIPA1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Norrie disease (pseudoglioma) (NDP) full gene sequence analysis


name: Level 5 molecular pathology procedure - Nuclear receptor subfamily 0, group B, member 1 (NR0B1) full gene sequence analysis


name: Level 5 molecular pathology procedure - PROP paired-like homeobox 1 (PROP1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Paired-like homeobox 2b (PHOX2B) full gene sequence analysis


name: Level 5 molecular pathology procedure - Pancreatic and duodenal homeobox 1 (PDX1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Peripherin 2 [retinal degeneration, slow] (PRPH2) full gene sequence analysis


name: Level 5 molecular pathology procedure - Polyglutamine binding protein 1 (PQBP1) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Potassium inwardly-rectifying channel, subfamily J, member 1 (KCNJ1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Potassium inwardly-rectifying channel, subfamily J, member 10 (KCNJ10) full gene sequence analysis


name: Level 5 molecular pathology procedure - Prion protein (PRNP) full gene sequence analysis


name: Level 5 molecular pathology procedure - Protease, serine, 1 (trypsin 1) (PRSS1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Proteolipid protein 1 (PLP1) deletion analysis


name: Level 5 molecular pathology procedure - Proteolipid protein 1 (PLP1) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Proteolipid protein 1 (PLP1) duplication analysis


name: Level 5 molecular pathology procedure - Ret proto-oncogene (RET) gene analysis for detection of 2647_2648delinsTT variant


name: Level 5 molecular pathology procedure - Ret proto-oncogene (RET) gene analysis for detection of A883F variant


name: Level 5 molecular pathology procedure - Ret proto-oncogene (RET) gene analysis for detection of M918T variant


name: Level 5 molecular pathology procedure - Ret proto-oncogene (RET) gene analysis for detection of M918T, 2647_2648delinsTT, and A883F variants


name: Level 5 molecular pathology procedure - Ret proto-oncogene (RET) gene analysis for detection of common variants


name: Level 5 molecular pathology procedure - Retinitis pigmentosa 1 (RP1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Rhodopsin (RHO) full gene sequence analysis


name: Level 5 molecular pathology procedure - SCO cytochrome oxidase deficient homolog 2 (SCO1L) (SCO2) full gene sequence analysis


name: Level 5 molecular pathology procedure - SH2 domain containing 1A (SH2D1A) full gene sequence analysis


name: Level 5 molecular pathology procedure - Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG) deletion analysis


name: Level 5 molecular pathology procedure - Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG) duplication analysis


name: Level 5 molecular pathology procedure - Serine peptidase inhibitor, Kazal type 1 (SPINK1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Serine/threonine kinase 11 (STK11) deletion analysis


name: Level 5 molecular pathology procedure - Serine/threonine kinase 11 (STK11) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Sodium channel, voltage-gated, type I, beta (SCN1B) full gene sequence analysis


name: Level 5 molecular pathology procedure- Solute carrier family 16, member 2 (thyroid hormone transporter) (SLC16A2) deletion analysis


name: Level 5 molecular pathology procedure - Solute carrier family 16, member 2 (thyroid hormone transporter) (SLC16A2) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Solute carrier family 16, member 2 (thyroid hormone transporter) (SLC16A2) duplication analysis


name: Level 5 molecular pathology procedure - Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (SLC25A20) duplication analysis


name: Level 5 molecular pathology procedure - Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 (SLC25A4) full gene sequence analysis


name: Level 5 molecular pathology procedure - succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa (SDHC) deletion analysis


name: Level 5 molecular pathology procedure - Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa (SDHC) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa (SDHC) duplication analysis


name: Level 5 molecular pathology procedure - Succinate dehydrogenase complex, subunit D, integral membrane protein (SDHD) full gene sequence analysis


name: Level 5 molecular pathology procedure - THAP domain containing, apoptosis associated protein 1 (THAP1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Tocopherol [alpha] transfer protein (TTPA) full gene sequence analysis


name: Level 5 molecular pathology procedure - Torsin family 1, member A [torsin A] (TOR1A) full gene sequence analysis


name: Level 5 molecular pathology procedure - Translational activator of mitochondrial encoded cytochrome c oxidase I (TACO1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Transthyretin (TTR) full gene sequence analysis


name: Level 5 molecular pathology procedure - Twist homolog 1 (Drosophila) (TWIST1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Tyrosinase [oculocutaneous albinism IA] (TYR) full gene sequence analysis


name: Level 5 molecular pathology procedure - UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) full gene sequence analysis


name: Level 5 molecular pathology procedure - Usher syndrome 1G (autosomal recessive) (USH1G) full gene sequence analysis


name: Level 5 molecular pathology procedure - V-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) full gene sequence analysis


name: Level 5 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) targeted sequence analysis of exon 12


name: Level 5 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) targeted sequence analysis of exon 14


name: Level 5 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) targeted sequence analysis of exon 17


name: Level 5 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) targeted sequence analysis of exon 7


name: Level 5 molecular pathology procedure - V-raf-1 murine leukemia viral oncogene homolog 1 (RAF1) targeted sequence analysis of exons 7, 12, 14, and 17


name: Level 5 molecular pathology procedure - Von Willebrand factor (VWF) targeted sequence analysis of exon 26


name: Level 5 molecular pathology procedure - Von Willebrand factor (VWF) targeted sequence analysis of exon 27


name: Level 5 molecular pathology procedure - Von Willebrand factor (VWF) targeted sequence analysis of exons 26, 27, and 37


name: Level 5 molecular pathology procedure - Zinc finger E-box binding homeobox 2 (ZEB2) deletion analysis


name: Level 5 molecular pathology procedure - Zinc finger E-box binding homeobox 2 (ZEB2) deletion and duplication analysis


name: Level 5 molecular pathology procedure - Zinc finger E-box binding homeobox 2 (ZEB2) duplication analysis


name: Level 5 molecular pathology procedure - Zinc finger protein 41 (ZNF41) full gene sequence analysis


name: Level 6 molecular pathology procedure - Actin, alpha 2, smooth muscle, aorta (ACTA2) full gene sequence


name: Level 6 molecular pathology procedure - Acyl-CoA dehydrogenase, C-2 to C-3 short chain (ACADS) full gene sequence analysis


name: Level 6 molecular pathology procedure - Ankyrin repeat domain 1 (ANKRD1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Aprataxin (ACTC1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Aprataxin (APTX) full gene sequence analysis


name: Level 6 molecular pathology procedure - Arylsulfatase A (ARSA) full gene sequence analysis


name: Level 6 molecular pathology procedure - BCS1-like (S. cerevisiae) (BCS1L) full gene sequence analysis


name: Level 6 molecular pathology procedure - Bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2) deletion analysis


name: Level 6 molecular pathology procedure - Bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2) duplication analysis


name: Level 6 molecular pathology procedure - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) full gene sequence analysis


name: Level 6 molecular pathology procedure - COX10 homolog, cytochrome c oxidase assembly protein (COX10) full gene sequence analysis


name: Level 6 molecular pathology procedure - COX15 homolog, cytochrome c oxidase assembly protein (COX15) full gene sequence analysis


name: Level 6 molecular pathology procedure - Calcium-sensing receptor (CASR) full gene sequence analysis


name: Level 6 molecular pathology procedure - Calsequestrin 2 (cardiac muscle) (CASQ2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Cholinergic receptor, nicotinic, alpha 4 (CHRNA4) full gene sequence analysis


name: Level 6 molecular pathology procedure - Cholinergic receptor, nicotinic, beta 2 (neuronal) (CHRNB2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Chymotrypsin C (CTRC) full gene sequence analysis


name: Level 6 molecular pathology procedure - Coproporphyrinogen oxidase (CPOX) full gene sequence analysis


name: Level 6 molecular pathology procedure - Cyclin-dependent kinase-like 5 (CDKL5) deletion analysis


name: Level 6 molecular pathology procedure - Cyclin-dependent kinase-like 5 (CDKL5) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Cyclin-dependent kinase-like 5 (CDKL5) duplication analysis


name: Level 6 molecular pathology procedure - Cytochrome P450, family 11, subfamily B, polypeptide 1 (CYP11B1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Cytogenomic constitutional targeted microarray analysis of chromosome 22q13 by interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants for chromosomal abnormalities


name: Level 6 molecular pathology procedure - D 7-dehydrocholesterol reductase (DHCR7) full gene sequence analysis


name: Level 6 molecular pathology procedure - DNA sequence analysis of 6-10 exons


name: Level 6 molecular pathology procedure - Deafness, autosomal recessive 59 (DFNB59) full gene sequence analysis


name: Level 6 molecular pathology procedure - Deoxyguanosine kinase (DGUOK) full gene sequence analysis


name: Level 6 molecular pathology procedure - Desmin (DES) full gene sequence analysis


name: Level 6 molecular pathology procedure - Dihydrolipoamide branched chain transacylase E2 (DBT) deletion analysis


name: Level 6 molecular pathology procedure - Dihydrolipoamide branched chain transacylase E2 (DBT) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Dihydrolipoamide branched chain transacylase E2 (DBT) duplication analysis


name: Level 6 molecular pathology procedure - Doublecortin (DCX) full gene sequence analysis


name: Level 6 molecular pathology procedure - Emerin (EMD) full gene sequence analysis


name: Level 6 molecular pathology procedure - Endoglin (ENG) deletion analysis


name: Level 6 molecular pathology procedure - Endoglin (ENG) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Endoglin (ENG) duplication analysis


name: Level 6 molecular pathology procedure - Eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa (EIF2B2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Eyes absent homolog 1 [Drosophila] (EYA1) deletion analysis


name: Level 6 molecular pathology procedure - Eyes absent homolog 1 [Drosophila] (EYA1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Eyes absent homolog 1 [Drosophila] (EYA1) duplication analysis


name: Level 6 molecular pathology procedure - FtsJ RNA methyltransferase homolog 1 (E. coli) (FTSJ1) deletion analysis


name: Level 6 molecular pathology procedure - FtsJ RNA methyltransferase homolog 1 (E. coli) (FTSJ1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - FtsJ RNA methyltransferase homolog 1 (E. coli) (FTSJ1) duplication analysis


name: Level 6 molecular pathology procedure - Fumarate hydratase (FH) full gene sequence analysis


name: Level 6 molecular pathology procedure - GTP cyclohydrolase 1 (GCH1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Galactosidase, alpha (GLA) full gene sequence analysis


name: Level 6 molecular pathology procedure - Ganglioside-induced differentiation-associated protein 1 (GDAP1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Gene analysis of 6-10 exons using mutation scanning method


name: Level 6 molecular pathology procedure - Glial fibrillary acidic protein (GFAP) full gene sequence analysis


name: Level 6 molecular pathology procedure - Growth hormone releasing hormone receptor (GHRHR) full gene sequence analysis


name: Level 6 molecular pathology procedure - HNF1 homeobox A (HNF1A) full gene sequence analysis


name: Level 6 molecular pathology procedure - HNF1 homeobox B (HNF1B) full gene sequence analysis


name: Level 6 molecular pathology procedure - HtrA serine peptidase 1 (HTRA1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Iduronate 2-sulfatase (IDS) full gene sequence analysis


name: Level 6 molecular pathology procedure - Isoprenoid synthase domain containing (ISPD) full gene sequence analysis


name: Level 6 molecular pathology procedure - Kirsten rat sarcoma viral oncogene homolog (KRAS) full gene sequence


name: Level 6 molecular pathology procedure - Low density lipoprotein receptor (LDLR) deletion analysis


name: Level 6 molecular pathology procedure - Low density lipoprotein receptor (LDLR) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Low density lipoprotein receptor (LDLR) duplication analysis


name: Level 6 molecular pathology procedure - Lysosomal-associated membrane protein 2 (LAMP2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Mannose phosphate isomerase (MPI) full gene sequence analysis


name: Level 6 molecular pathology procedure - Methylmalonic aciduria (cobalamine deficiency) type A (MMAA) full gene sequence analysis


name: Level 6 molecular pathology procedure - Methylmalonic aciduria (cobalamine deficiency) type B (MMAB) full gene sequence analysis


name: Level 6 molecular pathology procedure - Multiple endocrine neoplasia I (MEN1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Myelin protein zero (MPZ) full gene sequence analysis


name: Level 6 molecular pathology procedure - Myosin, light chain 2, regulatory, cardiac, slow (MYL2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Myotilin (MYOT) full gene sequence analysis


name: Level 6 molecular pathology procedure - Myotubularin 1 (MTM1) deletion analysis


name: Level 6 molecular pathology procedure - Myotubularin 1 (MTM1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Myotubularin 1 (MTM1) duplication analysis


name: Level 6 molecular pathology procedure - NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (NDUFS7) full gene sequence analysis


name: Level 6 molecular pathology procedure - NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa [NADH-coenzyme Q reductase] (NDUFS8) full gene sequence analysis


name: Level 6 molecular pathology procedure - NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa (NDUFV1) full gene sequence analysis


name: Level 6 molecular pathology procedure - Nephronophthisis 1 (juvenile) (NPHP1) deletion analysis


name: Level 6 molecular pathology procedure - Nephronophthisis 1 (juvenile) (NPHP1) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2) full gene sequence analysis


name: Level 6 molecular pathology procedure - Neurofibromin 2 (merlin) (NF2) deletion analysis


name: Level 6 molecular pathology procedure - Neurofibromin 2 (merlin) (NF2) deletion and duplication analysis


name: Level 6 molecular pathology procedure - Neurofibromin 2 (merlin) (NF2) duplication analysis